Dr. Hong received his Bachelor of Medicine (MD equivalent) degree from Shanghai Medical University, China; Master of Science degree in Epidemiology from Erasmus University Rotterdam, the Netherlands; and Doctor of Philosophy degree in Epidemiology from the Karolinska Institute, Stockholm, Sweden.
Dr. Yuling Hong is Associate Director for Science at the Division for Heart Disease and Stroke Prevention, US Centers for Disease Control and Prevention.
He directed the American Heart Association Statistics and Epidemiology Unit for 8 years. Prior to that, he was a faculty member at the Washington University School of Medicine, St. Louis, Missouri. His research interests include cardiovascular disease epidemiology, surveillance and prevention, scientific database management, quality of care and outcomes research, genetic epidemiology, and evidence-based guideline development. Dr. Hong has published more than 140 peer-reviewed publications and has been an ad-hoc reviewer for more than 30 scientific journals. He has served on several research grant peer review groups, committee, or panels. Dr. Hong is a fellow of AHA.
Areas of Interest
- Cardiovascular Diseases
- Disease Surveillance
- Genetic Epidemiology
- Health Outcomes
Affiliations & Activities
Dr. Yuling Hong is currently the Associate Director for Science in the Division for Heart Disease and Stroke Prevention of Centers for Disease Control and Prevention.
- Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, Miller EPR 3rd, Polonsky T, Thompson-Paul AM, Vupputuri S, 2018, Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Journal of American College of Cardiology , 71, 2176-2198
- Ritchey M, Chang A, Powers C, Loustalot F, Schieb L, Ketcham M, Durthaler J, Hong Y., 2016, Vital Signs: Disparities in Antihypertensive Medication Nonadherence among Medicare Part D Beneficiaries - United States, 2014, Morbidity and Mortality Weekly Report, 65, 967-76
- George MG, Hong Y, Bowman BA., 2015, Improving blood pressure for brain and heart health, Public Health Reports, 130, 302-306
- Bi Z, Liang X, Xu A, Wang L, Shi X, Zhao W, Ma J, Guo X, Zhang X, Zhang J, Ren J, Yan L, Lu Z, Wang H, Tang J, Cai X, Dong J, Zhang J, Chu J, Engelgau M, Yang Q, Hong Y, Wang Y., 2014, Hypertension prevalence, awareness and control and dietary sodium intake in Shandong Province, China: Findings from the baseline survey for the Shandong & Ministry of Health Action on Salt and Hypertension (SMASH) Project, Preventing Chronic Disease, ,
- Ritchey MD, Loustalot F, Bowman BA, Hong Y. , 2014, Trends in US Heart Disease Mortality During the Beginning of the 21st Century, Journal of American Medical Association, 312, 2037-2039
- Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD, 2010, American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond, Circulation, 121, 586-613
- Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O’Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, 2006, Heart Disease and Stroke Statistics--2006 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 113, 85-151
- Hong Y, Pedersen N, Brismar K, de Faire U, 1997, Genetic and environmental architecture of the features of Insulin-Resistance Syndrome, American Journal of Human Genetics, 60, 143-152